In the News… More ADA Controversy, Insulin pricing bill, Setback for GLP-1 and T1D, Dexcom 15-day expands converage, and more!

On this episode of Diabetes Connections In the news… More accusations of censorship at the ADA, a setback for GLP1 medications for type 1, discussion of a federal insulin price cap, device news and mergers and and much more. Check out our fall in-person events: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message…

In the News… Dexcom G8 details, GLP-1 T1D studies, Pump + CGM all-in-one update, cannabis for diabetes and more!

It’s In The News, where we bring you the top diabetes stories and headlines happening now. Top stories this week: Dexcom shares details of its next generation CGM, T1D and GLP-1 studies, weight loss management on GLP-1 medications updates, all-in-one CGM and pump, and more! Announcing Community Commericals! Learn how to get your message on…

In the News… Universal T1D screening studied, Dexcom new product, Afrezza prescribing guidelines update, and more!

It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: UK looks at starting universal T1D screening, Dexcom’s CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing…

In the News… Libre Freestyle recall, Dexcom 15 day launch, Omnipod & Tandem updates, Medicare price adjustments and more!

It’s In the News.. a look at the top headlines and stories in the diabetes community. This week’s top stories: big FDA recall around Freestyle Libre (see more below to find out if you’re affected), Dexcom launches their 15.5 day sensor, Omnipod announces enhancements, Tandem tests a fully closed loop (with high fat, high carb…